Association between disease modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis
Solomon DH, Massarotti E, Garg R et al.
JAMA 2011;305:2525–31.
The use of tumor necrosis factor inhibitors or hydroxychloroquine is associated with a lower incidence of diabetes mellitus in patients with rheumatoid arthritis or psoriasis compared with the use of other non-biologic disease-modifying antirheumatic drugs.
» Read an expert review of this paper